idoxuridine structure
|
Common Name | idoxuridine | ||
---|---|---|---|---|
CAS Number | 54-42-2 | Molecular Weight | 354.099 | |
Density | 2.1±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C9H11IN2O5 | Melting Point | 194 °C(lit.) | |
MSDS | USA | Flash Point | N/A | |
Symbol |
GHS07, GHS08 |
Signal Word | Warning |
Use of idoxuridineIdoxuridine is an antiviral agent for feline herpesvirus type-1 with IC50 of 4.3 μM.Target: herpesvirus type-1Idoxuridine is mainly used topically to treat herpes simplex keratitis. Epithelial lesions, especially initial attacks presenting with a dendritic ulcer, are most responsive to therapy, while infection with stromal involvement are less responsive. Idoxuridine is ineffective against herpes simplex virus type 2 and varicella-zoster. |
Name | 5-iodo-2'-deoxyuridine |
---|---|
Synonym | More Synonyms |
Description | Idoxuridine is an antiviral agent for feline herpesvirus type-1 with IC50 of 4.3 μM.Target: herpesvirus type-1Idoxuridine is mainly used topically to treat herpes simplex keratitis. Epithelial lesions, especially initial attacks presenting with a dendritic ulcer, are most responsive to therapy, while infection with stromal involvement are less responsive. Idoxuridine is ineffective against herpes simplex virus type 2 and varicella-zoster. |
---|---|
Related Catalog | |
References |
Density | 2.1±0.1 g/cm3 |
---|---|
Melting Point | 194 °C(lit.) |
Molecular Formula | C9H11IN2O5 |
Molecular Weight | 354.099 |
Exact Mass | 353.971252 |
PSA | 104.55000 |
LogP | -0.52 |
Index of Refraction | 1.715 |
Water Solubility | 1.6 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335-H341-H361 |
Precautionary Statements | P280-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic |
Risk Phrases | R45;R46;R61 |
Safety Phrases | S53-S45 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | YU7700000 |
HS Code | 2934999090 |
~% idoxuridine CAS#:54-42-2 |
Literature: Journal of Molecular Catalysis B: Enzymatic, , vol. 95, p. 16 - 22 |
~96% idoxuridine CAS#:54-42-2 |
Literature: Kumar; Wiebe; Knaus Canadian Journal of Chemistry, 1994 , vol. 72, # 9 p. 2005 - 2010 |
~92% idoxuridine CAS#:54-42-2 |
Literature: Asakura, Jun-ichi; Robins, Morris J. Journal of Organic Chemistry, 1990 , vol. 55, # 16 p. 4928 - 4933 |
~% idoxuridine CAS#:54-42-2 |
Literature: US4851520 A1, ; |
~90% idoxuridine CAS#:54-42-2 |
Literature: Hatano, Akihiko; Harano, Aiko; Kirihara, Masayuki Chemistry Letters, 2006 , vol. 35, # 2 p. 232 - 233 |
~% idoxuridine CAS#:54-42-2 |
Literature: Journal of Organic Chemistry, , vol. 55, # 16 p. 4928 - 4933 |
~% idoxuridine CAS#:54-42-2 |
Literature: Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 34, # 6 p. 513 - 522 |
~% idoxuridine CAS#:54-42-2 |
Literature: Collection of Czechoslovak Chemical Communications, , vol. 59, # 10 p. 2303 - 2330 |
Precursor 8 | |
---|---|
DownStream 10 | |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
J. Sci. Ind. Res. 65(10) , 808, (2006) Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ... |
|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Chem. Res. Toxicol. 23 , 1215-22, (2010) Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ... |
|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Drug Metab. Dispos. 38 , 2302-8, (2010) Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predicti... |
5-Iodo-2'-desoxyuridine |
UNII-LGP81V5245 |
Dendrid (Trade name) |
5-Iodo-2'-Deoxyuridine |
Idoxene |
Idulea |
1-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-iodo-2,4(1H,3H)-pyrimidinedione |
idoxuridine |
STOXIL |
Ophthalmadine |
HERPLEX |
Uracil, 5-iodo-1-(2-deoxy-β-D-ribofuranosyl)- |
EINECS 200-207-8 |
1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5-iodpyrimidin-2,4(1H,3H)-dion |
Kerecid |
2′-Deoxy-5-iodouridine |
2'-Deoxy-5-iodouridine |
Virudox |
Uridine, 2'-deoxy-5-iodo- |
5-Iodo-2′-deoxyuridine |
MFCD00134656 |
Iduridin |